An interventional study of Gravitas FT and Gravitas FT Monitor guidance in Nasogastric Tube, sponsored by Gravitas Medical, Inc.. Active, not recruiting at 5 sites in United States. Open to participants aged 0 Weeks to 2 Years. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Gravitas Medical, Inc. · Not applicable, Interventional, and Other
The purpose of this study is to validate the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.
Gravitas Medical, Inc. is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Gravitas FT and Gravitas FT Monitor guidance
FT placed with guidance from the Gravitas FT system
Incidence of device and procedure-related adverse events that occur while the feeding tube is within a subject. The number and type of adverse events will be collected.
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gravitas Medical, Inc.